The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target

Henderson, John, Distler, Joerg and O'Reilly, Steven (2019) The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target. Trends in Molecular Medicine, 25 (5). pp. 395-411. ISSN 1471-4914

Full text not available from this repository. (Request a copy)

Abstract

Systemic sclerosis (SSc) is a rare autoimmune disorder characterised by skin fibrosis that often also affects internal organs, eventually resulting in mortality. Although management of the symptoms has extended lifespan, patients still suffer from poor quality of life, hence the need for improved therapies. Development of efficacious treatments has been stymied by the unknown aetiology, although recent advancements suggest a potentially key role for epigenetics – the regulation of gene expression by noncoding RNAs and chemical modifications to DNA or DNA-associated proteins. Herein, the evidence implicating epigenetics in the pathogenesis of SSc is discussed with an emphasis on the therapeutic potential this introduces to the field – particularly the repurposing of epigenetic targeting cancer therapeutics and newly emerging miRNA-based strategies.

Item Type:	Article
Subjects:	C700 Molecular Biology, Biophysics and Biochemistry
Department:	Faculties > Health and Life Sciences > Applied Sciences
Depositing User:	Elena Carlaw
Date Deposited:	10 May 2019 13:49
Last Modified:	10 Oct 2019 19:02
URI:	http://nrl.northumbria.ac.uk/id/eprint/39260

Downloads